Pharmacist's Letter

March 2021 Issue

Share Facts About the New Viral Vector COVID-19 Vaccine

You'll hear buzz about the new single-dose "viral vector" COVID-19 vaccine from Johnson & Johnson/Janssen (Ad26.COV2.S)...

Resources

Chart: COVID-19 Vaccines

Reduce Risk of Injury and Manage Pain From IM Vaccinations

The COVID-19 vaccine rollout will put more focus on giving IM immunizations properly and helping patients manage a sore arm...

Weigh Pros and Cons of SMART for Moderate to Severe Asthma

You'll hear about Single Maintenance And Reliever Therapy ("SMART")...

Emphasize Nondrug Measures for Overactive Bladder...Not Meds

Gemtesa (vibegron) will be a new Rx med for overactive bladder...

GO TO FULL ISSUE

COVID-19

Injection

Treatments of Interest for COVID-19

Communicating About COVID-19 Vaccination

COVID-19 Testing FAQs

BROWSE MORE RESOURCES

CE & Training

Dyslipidemia Treatment Options

Chronic Heart Failure Management

Elderly Patients' Unique Med Needs

MORE CE COURSES

Popular Charts

Med Updates

Cabenuva
cabotegravir/rilpivirine
A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection

Winlevi
clascoterone
An androgen receptor inhibitor topical cream for acne

Gemtesa
vibegron
An oral beta-3 agonist for overactive bladder

MORE MED UPDATES